Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Related Citations for PubMed (Select 25042571)


A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.

Ellem SJ, Taylor RA, Furic L, Larsson O, Frydenberg M, Pook D, Pedersen J, Cawsey B, Trotta A, Need E, Buchanan G, Risbridger GP.

J Pathol. 2014 Sep;234(1):86-98. doi: 10.1002/path.4386. Epub 2014 Jul 9.


Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.

Rhodes LV, Antoon JW, Muir SE, Elliott S, Beckman BS, Burow ME.

Mol Cancer. 2010 Nov 18;9:295. doi: 10.1186/1476-4598-9-295.


Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.

Frigo DE, Sherk AB, Wittmann BM, Norris JD, Wang Q, Joseph JD, Toner AP, Brown M, McDonnell DP.

Mol Endocrinol. 2009 Sep;23(9):1385-96. doi: 10.1210/me.2009-0010. Epub 2009 May 21.


Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.

Yu S, Xia S, Yang D, Wang K, Yeh S, Gao Z, Chang C.

Med Oncol. 2013;30(3):674. doi: 10.1007/s12032-013-0674-9. Epub 2013 Aug 8.


Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.

Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.

Cancer Res. 2009 Jul 15;69(14):5793-800. doi: 10.1158/0008-5472.CAN-08-4924. Epub 2009 Jul 7.


SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.

Uygur B, Wu WS.

Mol Cancer. 2011 Nov 10;10:139. doi: 10.1186/1476-4598-10-139.


Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.

Orr B, Riddick AC, Stewart GD, Anderson RA, Franco OE, Hayward SW, Thomson AA.

Oncogene. 2012 Mar 1;31(9):1130-42. doi: 10.1038/onc.2011.312. Epub 2011 Aug 1.


The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.

Arya M, Patel HR, McGurk C, Tatoud R, Klocker H, Masters J, Williamson M.

J Exp Ther Oncol. 2004 Dec;4(4):291-303.


The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor.

Kasina S, Macoska JA.

Mol Cell Endocrinol. 2012 Apr 4;351(2):249-63. doi: 10.1016/j.mce.2011.12.015. Epub 2012 Jan 8.


PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling.

Conley-LaComb MK, Saliganan A, Kandagatla P, Chen YQ, Cher ML, Chinni SR.

Mol Cancer. 2013 Jul 31;12(1):85. doi: 10.1186/1476-4598-12-85.


MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Verghese ET, Drury R, Green CA, Holliday DL, Lu X, Nash C, Speirs V, Thorne JL, Thygesen HH, Zougman A, Hull MA, Hanby AM, Hughes TA.

J Pathol. 2013 Nov;231(3):388-99. doi: 10.1002/path.4248.


Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis.

Hall JM, Korach KS.

Mol Carcinog. 2013 Sep;52(9):715-25. doi: 10.1002/mc.21913. Epub 2012 Apr 30.


The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.

Bonkhoff H, Berges R.

Eur Urol. 2009 Mar;55(3):533-42. doi: 10.1016/j.eururo.2008.10.035. Epub 2008 Nov 6. Review.


A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.

Clark AK, Taubenberger AV, Taylor RA, Niranjan B, Chea ZY, Zotenko E, Sieh S, Pedersen JS, Norden S, Frydenberg M, Grummet JP, Pook DW; Australian Prostate Cancer BioResource, Stirzaker C, Clark SJ, Lawrence MG, Ellem SJ, Hutmacher DW, Risbridger GP.

Biomaterials. 2013 Jul;34(20):4777-85. doi: 10.1016/j.biomaterials.2013.03.005. Epub 2013 Apr 2.


Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

Ao M, Franco OE, Park D, Raman D, Williams K, Hayward SW.

Cancer Res. 2007 May 1;67(9):4244-53.


CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.

Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM.

Neoplasia. 2012 Aug;14(8):709-18.


Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.

Boudot A, Kerdivel G, Habauzit D, Eeckhoute J, Le Dily F, Flouriot G, Samson M, Pakdel F.

PLoS One. 2011;6(6):e20898. doi: 10.1371/journal.pone.0020898. Epub 2011 Jun 10.


Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.

Kaminski A, Hahne JC, Haddouti el-M, Florin A, Wellmann A, Wernert N.

Int J Mol Med. 2006 Nov;18(5):941-50.


Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.

Chen G, Chen SM, Wang X, Ding XF, Ding J, Meng LH.

J Biol Chem. 2012 Apr 6;287(15):12132-41. doi: 10.1074/jbc.M111.302299. Epub 2012 Feb 15. Erratum in: J Biol Chem. 2012 Jun 1;287(23):19336.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk